Jaunt’s Post

Check out the latest report from 𝐈𝐧𝐭𝐞𝐥𝐥𝐞𝐜𝐭𝐮𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 Covers Various 𝐑𝐞𝐠𝐢𝐨𝐧𝐬 Including:  #NorthAmerica #Europe #AsiaPacific #LatinAmerica and #Africa. Don't miss out on this opportunity to stay informed about the latest trends in the Industry. Endometrial Ablation Devices Market Size, Share & Trends Analysis Report By #Technology (Radiofrequency Ablation, Cryoablation, Hydrothermal Ablation, Thermal Balloon, Hysteroscopic Ablation, Others), By #EndUser (Ambulatory Surgery Center, Clinic, Hospital), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028. IMIR Market Research Pvt. Ltd. 📚𝐆𝐞𝐭 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐀𝐭 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭𝐞𝐝 𝐏𝐫𝐢𝐜𝐞:📝👇https://lnkd.in/dafYGVvr 📚𝐑𝐞𝐩𝐨𝐫𝐭 𝐅𝐨𝐜𝐮𝐬𝐞𝐝 𝐎𝐧 𝐓𝐨𝐩 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬: Minerva Surgical, Inc. Channel Medsystems Microsulis Medical Limited Evergreen Women's Health OMNITECH Systems AEGEA Medical, Inc. AngioDynamics Boston Scientific Channel Medsystems CooperSurgical Delmont Imaging EMOS Technology GmbH Ethicon, Inc. by Johnson & Johnson Gynesonics, Inc. Hologic, Inc. Hologic (Formerly Gen-Probe) Hospiinz International Idoman KARL STORZ Medtronic Minerva Surgical, Inc. Olympus Corporation Richard Wolf GmbH Smith+Nephew CooperCompanies VELDANA MEDICAL SA JUNE MEDICAL #Endometrial #AblationDevices #Ablation #Devices #Marketresearchreports #Size #Share #Trends #Growth #Opportunity #Outlook #Forecast #covid19 #Segments #KeyPlayers #RegionsOutlook #GrowthPotential #PriceTrends #CompetitiveMarket #Forecast #2022to2028

Check out the latest report from IMIR Market Research Pvt. Ltd. on the 𝗔𝗿𝘁𝗶𝗳𝗶𝗰𝗶𝗮𝗹 𝗥𝗲𝘁𝗶𝗻𝗮 𝗠𝗮𝗿𝗸𝗲𝘁 Outlook and Geography Forecast till 2028 Don't miss out on this opportunity to stay informed about the latest trends in the industry. Artificial Retina Market Size, Share & Trends Analysis Report By Type (Suprachoroidal Implants, Epiretinal Implants, Subretinal Implants, Others), By End-use (Research Institutes, Hospitals, Ophthalmic Clinics, Others), Global Economy Insights, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023 - 2031. 📚 𝐆𝐞𝐭 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐚𝐭 𝐝𝐢𝐬𝐜𝐨𝐮𝐧𝐭𝐞𝐝 𝐩𝐫𝐢𝐜𝐞:👇 https://lnkd.in/dXG4wuBn 📚𝐓𝐨𝐩 𝐌𝐨𝐫𝐞 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐀𝐫𝐞::👇 Aetna, a CVS Health Company. Alcon Altris AI Altris AB. Axorus Bausch + Lomb Bionic Vision Australia Bionic Vision Technologies ZEISS Group Forus Health Intelligent Medical Implants Ltd Intelligent Retinal Imaging Systems - IRIS Johnson & Johnson Vision Labtician Ophthalmics Inc.. LambdaVision, Inc. Mediwhale Medtronic MORCHER GmbH Nano Retina NIDEK USA. NIDEK Technologies Srl  Notal Vision Optobionics Corporation Pixium Vision S.A. Ramsay Health Care UK Retina Implant RetInSight Samsara Vision Second Sight Inc STAAR Surgical USC Roski Eye Institute Vivani 

At Elos Medtech, our team of engineers specializing in spinal surgery bring an innovative approach to onboarding new projects. Our method sets us apart from the rest, as we prioritize the inclusion of key personnel with specialized expertise right from the outset. By integrating spinal, medical and engineering know-how at the initial stages, we ensure a comprehensive understanding of the project's requirements, challenges and objectives. Our unique strategy is not just about assembling a skilled team; it's about creating a synergy that allows us to anticipate potential hurdles and devise the most efficient pathways forward. This holistic approach has proven to be invaluable, significantly reducing time to market and enhancing efficiency for our clients. We believe that the success of a project lies not just in its completion, but in the journey it takes from conception to realization. That's why, at Elos Medtech, we ensure that every project benefits from our full spectrum of expertise, ensuring a smoother, more efficient process that meets our high standards and exceeds our customers' expectations. Discover the difference that dedicated expertise and thoughtful onboarding can make for your next project! #spine #ElosMedtech #CDMO #Medicaldevices

Are you drowning in a sea of MedTech data and missing out on crucial insights, missing out on early warning signs, failing to see the opportunities in front of them? IQVIA MedTech Global Data Insights – now available for the orthopedics segment - is designed to help you quickly and efficiently get answers to the questions that define your business. This first-of-kind platform enables companies to track evolving market trends, make smarter decisions and respond fast to shifting market dynamics. Read more about IQVIA MedTech Global Data Insights: https://bit.ly/3OEmIwL #MedTech #orthopedics

We support our customers with 160+ years of collective #MedTech expertise, we're not just talking the talk – we mean business. Join us as we unwrap our legacy, spotlighting our longer-tenured team:    Kristien Esser - 26 years: Guided Solutions' founder, shaping the MedTech recruitment landscape since the age of 26. His visionary leadership has been the driving force behind our success, challenging conventional recruitment norms and shaping the very foundations of who we are.    Darren Collier - 22 years: A cornerstone of our MedTech knowledge for over two decades, Darren specialises in medical imaging and radiotherapy, playing a pivotal role in fortifying our organisational prowess.    Jonathan Kerriss - 20 years: Navigating directorial responsibilities while pioneering Team Build services, Jonathan brings over two decades of expertise with a soft spot for Orthopaedics.     David Gray - 19 years: Specialising in EMEA team builds, David has a proven track record in propelling companies to commercial success, particularly in cardiology, vascular, and neuromodulation.     Tessa Fletcher - 16 years of experience - Starting as a Personal Assistant and advancing into recruitment, Tessa's journey reflects the organisation's dedication to continuous development.    Nicole Shield - 14 years: Director of our Aesthetics’ division bringing over a decade of expertise to our team, Nicole is currently building long-lasting relationships with the leaders of Medical Aesthetics globally.     Damé Medarski - 12 years: Our digital transformation leader since 2012, Damé has also been instrumental in driving our global expansion and engagement with some of the most innovative MedTech companies.     Adriana (Ani) Medarski - 10 years - Contributing a decade of invaluable expertise to Guided Solutions, Ani has played a major role in managing relationships with customers and candidates, streamlining processes, and ensuring we stay on top of industry trends.     Megan Percival - 9 years - A dynamic force within our team, Megan adeptly navigates various facets of our field. Her versatility and proactive approach make substantial contributions to enhancing our team's agility and overall effectiveness.    Silviya Totevska - 7 years - With seven years of dedicated service, Silviya exemplifies commitment and proficiency. Her contributions enhance our collective capability to swiftly and efficiently connect with top MedTech talent.    Iskra Gross - 5 years of experience - Specialising in the DACH region, Iskra has forged strong connections with clients and candidates. Her strategic presence has made a lasting impact in the region, solidifying Guided Solutions as a trusted partner to the DACH market.    And alongside these seasoned professionals, our team is strengthened by many others who are at the start of a promising journey within the MedTech sector. Our combined experience tells a story of expertise, dedication, and ongoing success. 🚀 #ExecutiveSearch #GuidedSolutions

The teleradiology reading services and IT market is forecast to exceed $4.3bn annual revenue by 2027, accordingly to Signify Research Ltd latest Teleradiology report. As such, intensified interest from private equity and imaging IT vendors is unsurprising, with the recent announcement by HealthEdge Investment Partners and Radsource building on a solid year of M&A and investment in 2023. Unfortunately there is limited information as to how the investment will be used, but for a sub-specialist vendor such as Radsource (orthopaedic and neurological #MRI interpretations), alongside having it's own PACS solution (ProtonPACS, built in partnership with Intelerad). The two most likely routes I'd expect is either, M&A to expand interpretation coverage - MRI is a fast growing segment, especially in the US, but is forecast to represent less than a quarter of total US teleradiology reading volume by 2027. Alternatively (or additionally...) the investment in technology such as #AI to optimise existing technology workflows and improve radiologist efficiency. If you'd like to discuss the teleradiology market and our latest research, please get in touch! #privateequity #imagingIT #teleradiology Signify Research Ltd | Matthew Watson

Explore the World of MedTech & HealthTech Innovators! We've just published a fresh blog, shining the spotlight on three cutting-edge companies transforming healthcare: Caristo Diagnostics, Abingdon Health plc, and Fundamental Surgery . From AI-driven cardiovascular diagnostics to groundbreaking virtual reality surgical training, these companies are revolutionising the industry and saving countless lives. 💡 Learn more about their technologies and how they're shaping the future of medicine: https://bit.ly/49Mcjbg As a leading #MedTech and #HealthTech recruitment company, we're passionate about connecting top talent with the organisations driving change. If you're looking to make an impact in this ever-evolving sector, don't miss out on our latest opportunities in the field. Reach out to us, and together, let's create a healthier future! 💫👩⚕️🔬🧬🩺 #MedTech #HealthTech #AI #VirtualReality #diagnostics #recruitment #innovation

The last time that you had a medical procedure, did you stay overnight in a facility, or were you discharged the same day? Well, of course it depends on the type of procedure you had, but it may also depend on the country you are in. Day surgery is most prevalent - and has its roots - in the US, when three medical practitioners (Crawford Long, Horace Wells, and William Morton) performed hundreds of procedures with anesthesia in an “office setting” in the 1840s (there was a war going on). The US recognized the potential of early ambulation and economic advantages of day surgery. In 1962, UCLA opened the first outpatient surgery center. A boom in day surgery took place from 1985 to 1994, as the percentage of day surgeries out of all surgeries increased from 34% to 61%. During the 1980s, the UK was faced with an aging population (15% of the population > 65 y.o., similar to Singapore today) and rising healthcare expenditures. A series of audits and studies eventually led to the NHS Modernisation Agency Day Surgery Program. Day surgery spiked - from 2% of all surgeries in 1978, to 15% by 1989, and 70% by 2003. Canada experienced a similar transition between 1995-2006, as inpatient surgery dropped by 16% and outpatient surgery increased by 30%. Australia’s first day surgery opened in Victoria in 1982. Within 20 years, this had grown to 234 registered free-standing day surgery centers (last month, ICG announced our investment (subject to customary approvals) in Cura, the largest day surgery operator in Australia). A large part of the shift towards outpatient (aka day) surgery is the result of better pain management, infection control, and simply progression of medical technologies. But it is also driven by economic sustainability - the cost of caring for its aging populace will drain public finances. Singapore’s healthcare spending tripled from $3.7bn in 2010 to $11.3bn in 2019, to a projected $27bn by 2030 (according to DPM Lawrence Wong) - that’s nearly a ninefold increase in just two decades. Inpatient care is costly (relative to outpatient), yet Singapore currently has one of the highest proportion of inpatient care (56%) compared to other OECD countries - US (26%), Canada (37%), UK (47%), Australia (48%). Singapore will have to pivot how it delivers its healthcare solutions without compromising patient outcomes. We recognize the challenges, and are investing deeply to be part of the solution.

MedTech Founders: How do you target which markets to expand to? Selecting the right markets can make or break a company, especially those developing deep Tech. 🎧 Join me in ep 8 of Healthy Talk as I sit down with Business Unit Leader (Orthopaedic), Frederick Ching, as he shares his experience doing business development for the orthopaedic line, main considerations to market entry, and his motivation for working in deep MedTech. ⁠Osteopore (OSX.AX) is a Singapore-based company that 3d prints bioresorbable implants that support natural bone healing and reduce post-surgery complications. Osteopore products are used across all major continents. Topics covered: - Osteopore Orthopaedic applications - Commercialization process - Market entry considerations (Regulatory barriers, reimbursements & market potential, tapping on the right clinical expertise) - Motivations working in deep MedTech  🚀 Don't miss this enlightening discussion! Join me on this episode on  Spotify https://lnkd.in/gyaEpipx Apple Podcast https://lnkd.in/gekpru6H Subscribe now for more engaging discussions at the intersection of technology and healthcare. Stay curious, stay inspired, and delve into the world of #Medtech with us!

Do you have a data gap ? Have you checked our #medtech global data insights? Get in touch! IQVIA MedTech #data #insights